Table 2 Main characteristics of inmates according to the presence of a severe liver fibrosis assessed by transient elastography (n = 680), 2013–2014
From: HIV infection, viral hepatitis and liver fibrosis among prison inmates in West Africa
Median transient elastography measures | <9.5 KPa | ≥9.5 KPa | p | Total |
|---|---|---|---|---|
No severe liver fibrosis | Severe liver fibrosis | |||
(n = 659) | (n = 21) | (n = 680) | ||
Age (median, [IQR]) | 30 [24–35] | 31 [28–35] | 0.46 | 30 [24–35] |
State prison, n (%) | <0.01 | |||
Dakar (Senegal) | 329 (49.9) | 4 (19.0) | 333 (49.0) | |
Lome (Togo) | 328 (50.1) | 17 (81.0) | 347 (51.0) | |
Tobacco, n (%) | 0.98 | |||
No use | 264 (40.0) | 8 (38.1) | 272 (39.9) | |
Past use | 90 (13.7) | 3 (14.3) | 93 (13.7) | |
Present use | 305 (46.3) | 10 (47.6) | 315 (46.4) | |
Cannabis, n (%) | 0.41 | |||
No use | 436 (66.1) | 14 (66.7) | 450 (66.2) | |
Past use | 175 (26.6) | 4 (19.0) | 179 (26.3) | |
Present use | 48 (7.3) | 3 (14.3) | 51 (7.5) | |
Alcohol usea, n (%) | 0.19 | |||
No | 510 (77.4) | 16 (76.2) | 526 (77.4) | |
Current drinking | 91 (13.8) | 5 (23.8) | 96 (14.1) | |
Hazardous drinking | 58 (8.8) | 0 (0.0) | 58 (8.5) | |
Herbal medicineb, n (%) | <0.01 | |||
No use | 194 (29.4) | 4 (19.0) | 198 (29.1) | |
Occasional use | 409 (62.1) | 10 (47.6) | 419 (61.6) | |
Frequent use | 56 (8.5) | 7 (30.4) | 63 (9.3) | |
HIV testc, n (%) | 0.01 | |||
Negative | 644 (97.7) | 18 (85.7) | 662 (97.4) | |
Positive | 15 (2.3) | 3 (14.3) | 18 (2.6) | |
HBV testc, n (%) | <0.01 | |||
Negative | 581 (88.2) | 14 (66.7) | 595 (87.5) | |
Positive | 78 (11.8) | 7 (33.3) | 85 (12.5) | |
HCV testd, n (%) | <0.01 | |||
Negative | 657 (99.7) | 20 (95.2) | 677 (99.5) | |
Positive | 2 (0.3) | 1 (4.8) | 3 (0.5) | |
Body Mass Indexe | 22.8 [21.0–25.3] | 22.4 `[19.8–24.4] | 0.38 | 22.8 [21.0–25.3] |